BioSpace News Archive

Smart Meter, the leading provider of cellular Remote Patient Monitoring solutions, has recently been granted two groundbreaking patents, expanding its position as a healthcare technology innovator.

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces it has entered into an agreement with a Japanese distributor for the sales and distribution of its products into the Japanese market.

Cardiff Oncology, Inc. today announced that the findings of the Phase 1b portion of the Phase 1b/2 study for the second-line treatment of patients with KRAS-mutated metastatic colorectal cancer (mCRC) disclosed by Cardiff Oncology in August 2023 have been published in the peer-reviewed journal Clinical Cancer Research, a journal of the American Association for Cancer Research.

Epicore Biosystems today announced that it has received investment from Pegasus Tech Ventures (‘Pegasus’), a global venture capital firm based in Silicon Valley, and Denka Company Limited (‘Denka’), a Japan-based multinational technology and materials company.

Certis Oncology Solutions today announced that it raised $10 million in a Series C funding round, bringing total raised to $42 million.

Teva Canada Ltd. is recalling one lot of Pediatrix Acetaminophen Oral Solution after routine product testing found a higher than acceptable amount of acetaminophen in the affected lot (approximately 185mg/5mL rather than the approved and labelled 160mg/5mL).

Starton Therapeutics Inc. (“Starton” or the “Company”) announced today that it has filed a provisional patent application with the U.S. Patent and Trademark Office (USPTO) for Solid State Active Pharmaceutical Composition for Transdermal Drug Delivery, referred to by the Company as STARTICLES.

Nyxoah SA, a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea, announced, in anticipation of upcoming investor meetings, its strategic priorities for 2024.

R1 RCM Inc. (NASDAQ: RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that it has completed its previously announced acquisition of Acclara from Providence, one of the nation’s largest health systems.

Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced a series of data presentations supporting the use of the company’s HFX™ 10 kHz Therapy for patients with chronic pain.